Patients with atrial fibrillation undergoing total joint arthroplasty increase hospital burden

Journal of Bone and Joint Surgery

Volumn 95, Issue 17, 2013, Pages 1606-1611

  Aggarwal, Vinay K ^a   Tischler, Eric H ^a   Post, Zachary D ^a   Kane, Ian ^a   Orozco, Fabio R ^a   Ong, Alvin ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DABIGATRAN; HEMOGLOBIN; HEPARIN; WARFARIN; ANTICOAGULANT AGENT;

AGED; ANEMIA; ANTICOAGULANT THERAPY; ARTHROFIBROSIS; ARTHROPATHY; ARTICLE; BLOOD TRANSFUSION; BODY MASS; BRADYCARDIA; CARDIOGENIC SHOCK; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CAUSE OF DEATH; CELLULITIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEMATOMA; HEMATURIA; HEMOGLOBIN BLOOD LEVEL; HIP ARTHROPLASTY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYPOTENSION; INTERNATIONAL NORMALIZED RATIO; JOINT INSTABILITY; KNEE EXTENSOR MECHANISM FAILURE; KNEE PROSTHESIS; LENGTH OF STAY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MECHANICAL JOINT FAILURE; MEDICAL DEVICE COMPLICATION; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PARESTHESIA; PERIPROSTHETIC JOINT INFECTION; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; PROSTHETIC LOOSENING; RECTUM HEMORRHAGE; SEPSIS; SURGICAL INFECTION; TACHYCARDIA; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; URINARY TRACT INFECTION; URINE RETENTION; WOUND COMPLICATION; WOUND DEHISCENCE; ARTHROPLASTY; COST OF ILLNESS; INFECTION; MIDDLE AGED; PREVALENCE; REOPERATION; RETROSPECTIVE STUDY; RISK; STATISTICS; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT; ATRIAL FIBRILLATION; BLOOD TRANSFUSION; CASE-CONTROL STUDIES; COST OF ILLNESS; FEMALE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT READMISSION; POSTOPERATIVE COMPLICATIONS; PREVALENCE; PROSTHESIS-RELATED INFECTIONS; REOPERATION; RETROSPECTIVE STUDIES; RISK; TREATMENT OUTCOME;

EID: 84887251930     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.L.00882     Document Type: Article

References (27)

1. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, D'Agostino RB, Massaro JM, Beiser A, Wolf PA, Benjamin EJ. Lifetime risk for development of atrial fibrillation: The Framingham Heart Study. Circulation. 2004 Aug 31;110 (9) : 1042-6. Epub 2004 Aug 16.
2. Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol. 2009 Dec 1;104 (11) : 1534-9.
3. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001 May 9;285 (18) : 2370-5.
4. Wu EQ, Birnbaum HG, Mareva M, Tuttle E, Castor AR, Jackman W, Ruskin J. Economic burden and co-morbidities of atrial fibrillation in a privately insured population. Curr Med Res Opin. 2005 Oct;21 (10) : 1693-9.
5. Coyne KS, Paramore C, Grandy S, Mercader M, Reynolds M, Zimetbaum P. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health. 2006 Sep-Oct;9 (5) : 348-56.
6. Tamis JE, Steinberg JS. Atrial fibrillation independently prolongs hospital stay after coronary artery bypass surgery. Clin Cardiol. 2000 Mar;23 (3) : 155-9.
7. Song X, Sander SD, Johnson BH, Varker H, Amin AN. Impact of atrial fibrillation and oral anticoagulation on hospital costs and length of stay. Am J Health Syst Pharm. 2012 Feb 15;69 (4) : 329-38.
8. Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NA 3rd, Page RL, Ezekowitz MD, Slotwiner DJ, Jackman WM, Stevenson WG, Tracy CM, Fuster V, Ryd'en LE, Cannom DS, Le Heuzey JY, Crijns HJ, Lowe JE, Curtis AB, Olsson S, Ellenbogen KA, Prystowsky EN, Halperin JL, Tamargo JL, Kay GN, Wann L, Jacobs AK, Anderson JL, Albert N, Hochman JS, Buller CE, Kushner FG, Creager MA, Ohman EM, Ettinger SM, Stevenson WG, Guyton RA, Tarkington LG, Halperin JL, Yancy CW; 2011 Writing Group Members; 2006 Writing Committee Members; ACCF/AHA Task Force Members. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline) : A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011 Jan 4;123 (1) : 104-23. Epub 2010 Dec 20.
9. Singer DE, Albers GW, Dalen JE, Fang MC, Go AS, Halperin JL, Lip GY, Manning WJ; American College of Chest Physicians. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) . Chest. 2008 Jun;133 (6 Suppl) : 546S-592S.
10. Fang MC, Chang Y, Hylek EM, Rosand J, Greenberg SM, Go AS, Singer DE. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med. 2004 Nov 16;141 (10) : 745-52.
11. Parvizi J, Ghanem E, Joshi A, Sharkey PF, Hozack WJ, Rothman RH. Does ''excessive'' anticoagulation predispose to periprosthetic infection? J Arthroplasty. 2007 Sep;22 (6) (Suppl 2) : 24-8. Epub 2007 Jul 26.
12. Pellegrini VD Jr, Sharrock NE, Paiement GD, Morris R, Warwick DJ. Venous thromboembolic disease after total hip and knee arthroplasty: current perspectives in a regulated environment. Instr Course Lect. 2008;57: 637-61.
13. Cheung EV, Sperling JW, Cofield RH. Infection associated with hematoma formation after shoulder arthroplasty. Clin Orthop Relat Res. 2008 Jun;466 (6) : 1363-7. Epub 2008 Apr 18.
14. Jafri SM, Mehta TP. Periprocedural management of anticoagulation in patients on extended warfarin therapy. Semin Thromb Hemost. 2004 Dec;30 (6) : 657-64.
15. Krahn AD, Healey JS, Simpson CS, Essebag V, Sivakumaran S, Birnie DH. Anticoagulation of patients on chronic warfarin undergoing arrhythmia device surgery: wide variability of perioperative bridging in Canada. Heart Rhythm. 2009 Sep;6 (9) : 1276-9. Epub 2009 Jun 06.
16. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med. 1997 May 22;336 (21) : 1506-11.
17. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2011 update: A report from the American Heart Association. Circulation. 2011 Feb 1;123 (4) : e18-209. Epub 2010 Dec 15.
18. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007 Apr;89 (4) : 780-5.
19. Kurtz S, Mowat F, Ong K, Chan N, Lau E, Halpern M. Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002. J Bone Joint Surg Am. 2005 Jul;87 (7) : 1487-97.
20. Auer J, Weber T, Berent R, Ng CK, Lamm G, Eber B. Postoperative atrial fibrillation independently predicts prolongation of hospital stay after cardiac surgery. J Cardiovasc Surg (Torino) . 2005 Dec;46 (6) : 583-8.
21. Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, Dunn AS, Kunz R; American College of Chest Physicians. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141 (2 Suppl) : e326S-50S.
22. Chana R, Salmon L, Waller A, Pinczewski L. Warfarin management in patients on continuous anticoagulation therapy undergoing total knee replacement. J Bone Joint Surg Br. 2011 Nov;93 (11) : 1497-502.
23. Rhodes DA, Severson EP, Hodrick JT, Dunn HK, Hofmann AA. Discontinuation of warfarin is unnecessary in total knee arthroplasty. Clin Orthop Relat Res. 2010 Jan;468 (1) : 120-6.
24. Garwood CL, Hwang JM, Moser LR. Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies. Pharmacotherapy. 2011 Dec;31 (12) : 1208-20.
25. Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J. Periprosthetic joint infection: The incidence, timing, and predisposing factors. Clin Orthop Relat Res. 2008 Jul;466 (7) : 1710-5. Epub 2008 Apr 18.
26. Abdelsalam H, Restrepo C, Tarity TD, Sangster W, Parvizi J. Predictors of intensive care unit admission after total joint arthroplasty. J Arthroplasty. 2012 May;27 (5) : 720-5.
27. Bozic KJ, Smith AR, Mauerhan DR. Pay-for-performance in orthopedics: implications for clinical practice. J Arthroplasty. 2007 Sep;22 (6) (Suppl 2) : 8-12. Epub 2007 Jul 26.